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Ecophysiological determinants of the 
human skeletal system
AbstrAct 
This review assessed relationships between external factors and the level of joint pathology (hip, knee, 
ankle, elbow, shoulder, hands and feet) in humans with dysplastic arthritis, psoriatic arthritis, rheumatoid 
arthritis, Sjögren’s syndrome, systemic lupus erythematosus, systemic sclerosis, degenerative joint dis-
ease, ankylosing spondylitis, osteoporosis, osteomalacia and gout. The accumulation of physiologically 
different chemical elements in different types of bones in humans of different ages allows for a more 
accurate assessment of the causal quoted response from parallel biochemical systems. These allow 
a better understanding of the link between exposure arising from smoking, alcohol, drugs, diseases, 
heredity, effects of amalgam dental fillings, diet, food preferences, chemical elements, occupational and 
environmental exposure to toxicants, lipoperoxidation and pro-antioxidant reactions. 
Physiology of the osteoarticular system determines what is responsible for bone and long-term body 
accumulation of toxic metals, which may be involved in the pathogenesis of bone diseases. While re-
lationships between stressors, antioxidant system and bone condition predict potential risks in certain 
abnormalities and change oxidative stress. Elemental instability in the environment combined with salinity, 
acidity, redox potential and local changes in hydrochemical balance, enhances adverse effects. Processes 
of remodeling and bone mineralization continue throughout life and therefore may be a determinant of 
long-term accumulation of toxicants. 
Environmental issues affecting bioaccumulation of chemical elements in the osteoarticular system in hu-
mans is poorly understood. Alloplastic procedures, including the need for prostheses, supplemented by 
image layouts oxidative enzyme activities, as well as lipoperoxidation and the level of stress proteins, give 
a complete picture of skeletal response to external stressors. Simultaneously, the analysis of the impact 
of stressors on bones allows a more accurate tracing of causal quoted responses from parallel reactions. 
They have a direct relationship with stressors and affect the nature and degree of responses and defense 
capabilities. Thus they have a role in the diagnosis of diseases of the skeletal system.
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Introduction 
Key features of the skeleton are conditioned by the 
processes of bone resorption and formation, which can 
be disrupted by hormonal changes, age-related factors, 
changes in physical activity, stimulants, etc. [1–2]. There 
are few studies concerned with the analysis of the con-
centrations of chemical elements in bones. This is due 
to difficulties in the acquisition of suitable test material. 
Cash skeletal element is associated with hospitalization, 
where most analyzed bones are collected at the time of 
joint replacement procedures or biopsy. The elemental 
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composition of bones is influenced by gender, age, 
metabolic activity and the impact of environmental 
factors [3–6]. Studies show a strong influence of the 
environment on the elemental composition of skeletal 
system [7–8]. Changes in the concentration of chemical 
elements in bones may also be due to the presence of 
different levels of elements in soil and their secondary 
migration to bones. This process is also a result of the 
emission of chemical elements to the environment 
[5]. Disorders of mineral metabolism often cause os-
teoporosis. An important criterion for evaluating the 
effectiveness of osteoporosis treatment is to assess 
bone mineral density (BMD); [9–11] and biochemical 
markers of bone turnover (12). In addition, metabolic 
disorders associated with thyroid disease, kidney dis-
ease, pancreatitis or diabetes, can lead to secondary 
osteoporosis [13–16]. 
Degenerative joint diseases occur due to restricted 
physical activity, especially affecting hip and knee 
joints. Degenerative changes apply to all structures of 
the joint, i.e. articular cartilage, joint capsule, synovium, 
and periarticular structures. A variety of factors are in-
volved in the development of basic changes including 
biological, biomechanical, metabolic, inflammatory and 
immunological factors [17–18]. This leads to disruption 
of metabolic processes of the body and, finally, to the 
induction of reactive oxygen species generation (ROS). 
A number of studies describe the activity of antioxidant 
enzymes (superoxide dismutase SOD, catalase CAT, 
glutathione GSH, glutathione-peroxidase GPx, gluta-
thione-reductase GR), which are the body’s protective 
barrier against oxidative damage. These are highly 
specialized enzymes related to antioxidant activity 
[19–20]. The antioxidant barrier of the body is further 
enhanced by the presence of acute phase proteins, e.g. 
ceruloplasmin CP, ferritin FRT, and haptoglobin HPT, 
occurring mainly in the plasma. Their protective action 
is in the chelation of metal ions that are responsible for 
induction of free radicals [21]. Experiments dealing with 
relationships between the level of antioxidant enzymes 
activity, which are the body’s antioxidant barrier, and the 
degree of physical activity, have been completed. The 
studies included patients with short-term and long-term 
hypokinesia resulting in impaired physiological and bio-
chemical reactions of the body leading to degenerative 
arthritis and bone metabolism disturbances. However, 
these studies provide conflicting results and fail to 
identify a clear relationship between the condition of 
the antioxidant system and immobilization of the patient 
[22–25].
Some studies demonstrated a  positive effect of 
melatonin and copper supplementation on antioxidant 
enzymes [20, 25]. Reactive oxygen species initiate 
lipid peroxidation, which results in increased levels of 
malondialdehyde (MDA) in the body. However, MDA 
has cytotoxic and mutagenic effect and may contribute 
to carcinogenesis [26]. Studies have shown different 
results on the regularity of the action of the antioxidant 
system in the process of lipid peroxidation [27–28, 
22–24]. Nonetheless, it was found that an imbalance in 
the body’s oxidation and antioxidation system affected 
bone mineral density [29].
The activity of oxidative enzyme systems and the 
intensity of lipoperoxidation and protein levels during 
stress can give a complete picture of the body’s  re-
sponse to different environmental stressors. There-
fore, in future studies, spectroscopy measurement of 
fluorescence should be extended to include advanced 
glycation end products (AGEs); [30]. Simultaneously, 
analysis of the degree of accumulation of chemical 
elements in various types of bones in men and women 
of different ages at the same time can allow for a more 
accurate trancing of causal effect with reactions from 
biochemical systems. Furthermore, the impact of heavy 
metals on the skeletal system is multidirectional and 
the impairment of the osteoarticular system is the best 
known long-term effect [8, 21, 19]. Understanding 
of these conditions will contribute to a better under-
standing of the link between the exposure arising from 
smoking, the effects of amalgam dental fillings, diet and 
food preferences and the level of chemical elements, 
lipoperoxidation processes and pro-antioxidant reac-
tions on the skeletal system. 
For this survey we incorporated different stress 
factors (tobacco, alcohol, dental amalgams, diet, 
disease, hereditary conditions, occupational and 
environmental exposure to toxic agents), which in 
turn, may have a direct relationships with the level of 
chemical elements in the body. In this study we make 
relevant comparisons between the groups of external 
factors in the development of defense capabilities of 
the human. These results can be used in the diagnosis 
of diseases of the skeletal system, mainly rheumatoid 
arthritis, osteoporosis, osteomalacia, and arthritis). In 
addition, we show that destabilization of the economy of 
elemental contamination of the environment can trigger 
the response of the skeletal system to environmental 
stressors. Other studies have shown a negative impact 
of various elements of chemical reactions taking place in 
the human bone tissue [5–6, 11, 31–33]. Those studies 
have also established a causal and consecutive link 
between the concentration of chemical elements and 
the level of activity of antioxidant systems of the cartilage 
and bone, in the course of  bones and joints diseases 
[3, 5, 31–32]. 
Degenerative arthritis and osteopathy of joints and 
changes in the nature of osteoporosis usually occur in 
older individuals, often resulting in alloplastic proce-
dures, including the need for prostheses. Thus, the aim 
of this review is to analyze how supplemented image 
layouts, oxidative enzyme activities, a knowledge of li-
poperoxidation intensity and the level of stress proteins, 
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can give a complete picture of the response of the skel-
etal system to external stressors. Simultaneously, we 
analyzed the extent of accumulation of physiologically 
different elements in various types of bones in humans 
of different ages, which enables a more accurate trace 
causal quoted response from the parallel biochemical 
systems to be assessed. These studies make  possible 
to assess whether in humans the link exists between the 
exposure arising from smoking, the effects of amalgam 
dental fillings, as well as the diet and food preferences, 
and the level of chemical elements, lipoperoxidation 
processes and pro-antioxidant reactions. They are 
important for a better evaluation of patients, taking into 
account the possible stress factors (tobacco, alcohol, 
dental amalgams, diet, disease, hereditary, occupation-
al and environmental exposure to toxic agents). They 
highlight a direct relationship between the level of chem-
ical elements in bones and the nature and degree of 
response to these external stressors. They also highlight 
the importance of external factors in the development 
of defense capabilities of humans. These analyzes can 
also contribute to the diagnosis of musculoskeletal 
disorders (such as rheumatoid arthritis, osteoporosis, 
osteomalacia or degenerative diseases and arthritis). 
External and pathophysiological 
changes in the osteoarticular system
Diseases of the osteoarticular system are a major 
problem in modern medicine, since they affect  millions 
of women and men, and their treatment is  problematic 
from a medical and economic point of view [34–35]. 
The osteoarticular system is subjected to a variety of 
factors that affect normal functioning. The complexity of 
pathophysiological conditions of this system manifests 
itself in many systemic and multi-organ changes. 
Rheumatoid arthritis (RA) is dominated by inflam-
matory reactions of an autoimmune multiorgan nature, 
which often takeover as in other connective tissue 
diseases. The changes in structure of the joint in genet-
ically susceptible individuals, as a result of an abnormal 
immune response to the unknown antigen, result in 
impaired joint mobility due to synovial inflammation af-
fecting the joints symmetrically. The initial symptoms are 
pain and swelling, progressing to the irreversible loss 
of joint function. This results in progressive disability. 
The etiology of the disease is not fully understood, but 
some of the factors initiating the inflammatory process 
are chemicals, viruses, bacteria, immune disorders 
and injuries of joints [36–40]. On the other hand, os-
teoarthritis (OA) is a chronic disease of musculoskeletal 
system, most often occurring in the most loaded joints: 
the spine, hip and knee joints. Degenerative changes 
occur in all structures of the joint. Biological, biome-
chanical, metabolic, immunological and inflammatory 
reactions may be involved in the development of basic 
changes [17–18]. OA often develops in obese patients 
with type 2 of diabetes [14]. Dobrogowski et al. [40] 
reported that the direct cause of osteoarthritis is irregu-
larity in the continuity of joint cartilage and subchondral 
abnormalities in the bone [40] and the progressive 
degradation of articular cartilage and periarticular bone 
areas is a result of these pathologies. The characteristic 
radiographic bone spurs (osteophytes) with narrowing 
of the articular gap are observed. Ultimately, this leads 
to deformation of the joint, pain, limitation of movement 
and joint stiffness [40–44].
Osteoporosis affects people of all age groups, 
though there are a  number of risk factors (genetics, 
race, advanced age, female gender, family predispo-
sition, low physical activity, a diet low in calcium and 
vitamin D, medications and stimulants). It may also 
be affected by thyroid, kidney disease, pancreatitis 
and diabetes [13–16]. Susceptibility to bone fractures 
due to reduced bone mass and changes in the bone 
micro-architecture is a characteristic clinical symptom 
of osteoporosis. An important criterion for assessing 
the effectiveness of osteoporosis treatment is the 
assessment of bone mineral density (BMD) and bio-
chemical markers of bone turnover [10–11, 45–46]. 
These studies found radiological subperiosteal frac-
tures, alterations in trabecular bone, thinning of bone 
cortex, and increased transparency of bones affected 
by osteoporosis. Visible radiographic changes occur 
in the late period, when bone loss is greater than 30% 
[47]. Progressive disease leads to disability of the pa-
tient [41, 48–52]. This is particularly true for   fractures 
of the femoral neck, for which few patients return to 
full fitness. These fractures are typically characterized 
by a high percentage of mortality [53]. For this reason, 
examining bone tissue from patients undergoing hip 
replacement is of great value because it is one of the 
most serious sites of fragile fractures. Similar changes 
accompany osteomalacia (rickets in adults), where an 
additional risk factors include vitamin D deficiency in 
the diet or due to lack of sun exposure, and advanced 
age. Pathophysiological changes in osteomalacia are 
associated with impaired mineralization due to insuffi-
cient accumulation of calcium in bones. Histologically, 
bone trabeculae have the correct number and size, but 
are poorly calcified [54–56].
Gout is an arthritis caused by the accumulation 
of sodium urate crystals in synovial fluid, resulting in 
phagocytosis by neutrophils and activation of inflamma-
tory mechanisms, leading to the formation of deposits 
in joint tissues and other organs (kidney, skin). Hyper-
uricemia and elevated level of uric acid in the blood, 
which may be asymptomatic, yet contribute to attacks 
of acute arthritis, trophic appearance, and pathological 
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changes in the kidneys, joints and bone [57–58]. These 
symptoms are caused by tissue injury due to the precip-
itation of sodium urate crystals or hyperuricemia. The 
latter  may be initiated by stress, hunger, alcohol intake 
and metabolic acidosis [37, 59–60]. Thus the range of 
environmental conditions contributing to diseases of 
the osteoarticular system is very wide. Our own study 
[33] investigated the link between environmental factors 
and the reactions of oxidative enzyme systems in the 
course of diseases of bone and joints.
bone tissue and its metabolism under 
environmental stress
A  normal healthy osteoarticular joint system has 
two essential functions for the body: mechanical and 
metabolic. Bone and organs are protected by muscles, 
attached to the bone scaffolds to provide movement [2]. 
The role of the skeletal system in metabolism involves 
the production of blood cells, the storage of calcium, 
magnesium and phosphorus, and also the maintenance 
of the correct electrolyte balance. Trabecular bone and 
cortical bone are sensitive to the effects of xenobiotics 
and osteotropic hormones. This is due to the high met-
abolic activity of spongy bone. The response of bones 
to the internal factors (hormones, vitamins, IL-1, PGE2) 
and xenobiotics is expressed through bone remodeling 
and the process of carcinogenesis [2, 14, 61]. Exposure 
to heavy metals is a major risk factor influencing the 
bone tissue. Substances such as lead, cadmium, fluo-
ride, aluminum, vinyl chloride, and carbon disulfide have 
negative effects on bone and joints. These substances 
are widely used in industry and thus have  universal 
access to human bones.
Bones are the main site of lead accumulation 
through the life span. Lead toxicity for the osteoartic-
ular system is dependent on the age of the individual 
and dose received. Lead may be a potential factor for 
osteoporosis, affecting osteoblasts and osteoclasts 
both directly and indirectly [8, 56]. Lead can also block 
calcium channels competing with calcium ions [8]. 
However, the effects of lead on bone mineral density, 
are disputed in some studies [62]. No relationship 
between the presence of Pb and BMD (bone mineral 
density) in tibia and patella was found. In addition, cad-
mium, commonly found in the environment with lead, is 
a further source of contamination, hazardous to health, 
hence there have been numerous studies on its effects 
on the skeletal system. Cadmium causes demineraliza-
tion, osteomalacia, osteoporosis and deformation of 
bones. Individuals particularly vulnerable to the adverse 
effects of cadmium on the bones include the elderly and 
women during and after menopause [63–67]. Cadmium 
interferes with absorption and incorporation of calcium, 
which is an essential component of bone mineral con-
tent. Affected individuals often present hypocalcemia, 
because cadmium causes increased excretion of calci-
um in the urine, and inhibits the biosynthesis of calcitriol 
indirectly by inhibiting the absorption of calcium in the 
intestine [56, 63, 67, 68]. Although not directly, cadmium 
generates free radicals, which is a source of exposure 
of cells to oxidative stress [69]. Antioxidants affect the 
body by displacement (replacement) of metal ions 
necessary for the functioning of antioxidant enzymes 
with Cd [70]. Molecular and cellular mechanisms of Cd 
toxicity are complex and still under investigation.
The bone and joint osteovascular system has a role 
in aluminum accumulation [71–74]. This element, 
particularly in its ionic form in the environment, causes 
osteomalacia. Also chlorides cause decalcification of 
the bones of extremities (acrosteolysis) in people ex-
posed continuously [56]. In addition, carbon disulfide 
is known to interfere with bone mineralization [56–75]. 
Osteoporosis can be caused by chronic exposure of 
bone to corticosteroids, thyroid hormones, anticonvul-
sants and anti-thrombotics, e.g. heparin, and stimulants 
[56]. Bones are a key accumulation site of radioactive 
isotopes of strontium 90 and 226. Inserting 90Sr into 
bones causes demineralization, while 226Ra causes 
bone damage and contributes to the development of 
osteosarcoma  [56, 76, 77]. Smoking also affects bone 
tissue, especially in postmenopausal women. Smoking 
causes weakening of the function and interaction of 
calcium containing compounds- hydroxyapatites  and 
contributes to the loss of bone mass [32]. Coffee con-
sumption may cause a reduction in bone density [78] 
and influence on bone metabolism. Diabetes results in 
an increased risk of bone fractures [79]. Changes in 
the osteoarticular system can also be caused by me-
chanical factors in the environment (vibration, shock, 
stroke). Long-term high-frequency vibrations result in 
bone ossification abnormalities and deformities of the 
articular surfaces [31]. In a study by [33] the analysis 
of exposure to harmful external factors was based on 
patient surveys. The patients answered questions about 
lifestyle: physical activity, diet, addiction, economic 
status. The questionnaire also included questions about 
disease, including a history of medication use that may 
also affect bone and joints. This study concluded that 
there is a relationship between the degree of impact of 
external factors and the condition of the skeletal system 
and the state of bone tissue.
bone tissue in the instability of 
elemental management in the 
environment
We found several studies evaluating the influence of 
different external factors on the condition of the osteoar-
ticular system. One of the external factors conditioning 
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the status of osteoarticular system is smoking, which has 
an effect that weakens the function of calcium and its 
action in the bones, which contributes to the loss of bone 
mass. At the same time, smoking activates other accom-
panying factors and activates a similar activity [32 Sirola 
et al. 2003, 15 Chernyshowa et al. 2008)]. However, no 
relationship between the presence of lead and the rate of 
bone mineral density was found [62]. On the other hand, 
cadmium from smoking has just another action as a result 
of burning only one cigarette, 20 μg of toxic Cd is released 
into the body, which acts destructively on the structure 
of bones and joints [63 Alfvén et al. 2002]. Cadmium 
is a widespread environmental pollutant, hazardous to 
health and numerous studies on the effect of cadmium 
on the human osteoarticular system and human bones 
have been conducted. Cadmium toxicity is the cause 
of demineralization, osteomalacia and osteoporosis of 
bones [67 Jakubowski et al. 1995, 63 Alfvén et al. 2002, 
66 Nyhall-Wahlin et al. 2009]. Individuals particularly 
vulnerable to the adverse effects of cadmium include 
post-menopausal women [64 Lyn 2003, 65 Åkesson et 
al. 2006]. Molecular and cellular mechanisms of toxicity 
of Cd are complicated and are still under research. Cad-
mium generates free radicals, although not directly and is 
the source of exposure of cells to oxidative stress. This is 
the result of the inhibition of antioxidants by the displace-
ment of metal ions by Cd. This inhibition is known to affect 
the normal functioning of antioxidant enzymes [69–70]. 
Approximately 10% of bone mass is exchanged per 
year in a healthy person [80]. In addition, the physio-
logical reduction of bone mass occurs in people aged 
35–40 years [80]. For these reasons bone is a good bio-
marker of long-term accumulation of chemical elements 
due to this slow turnover. The elements within the bone 
tissue include Ba, Ca, Cu, Fe, K, Li, Mg, Na, P, S, Sr, 
and Zn. The bone tissue stores calcium, copper, iron, 
lead, cadmium [4, 6, 81–82]. Up to 99% of total body 
calcium is found in the bones. It is present in the bone 
tissue primarily as an insoluble form of hydroxyapatite 
crystals. That part of the calcium load, which can easily 
penetrate into the body fluid is small. 
The second element in terms of the percentage in 
bones is phosphorus, occurring in the form of insoluble 
calcium phosphate salts [31, 83]. Bone tissue readily 
absorbs toxic elements, mainly cadmium, lead, radium, 
strontium and plutonium, that could potentially be a sig-
nificant factor in the pathogenesis of diseases of bones 
and joints [5, 31]. The levels of these elements in the 
bones are influenced by age and gender. Studies by 
Kwapulinski et al. [5] and Zaichick et al. [6] show that 
the rib bones of healthy women have a greater content 
of Ca, Mg, Na, P and Sr, and a lower concentration of 
Fe, and Pb compared to the rib bones of men. The con-
centration of Ca, Mg and P in bones tends to decrease 
with age, regardless of sex, whilst the concentration 
of Fe increases with age in men’s  ribs [6]. A  strong 
relationship was identified between the concentration 
of Mn and Cd, and Pb and Fe in the femoral bone of 
coal mine, steel mills and gas station workers [8]. The 
level of chemical elements in bones, which depends 
on the impact of environmental factors, age, sex, and 
metabolic activity has been reported as early as in 
1987 [3]. Changes in the concentration of chemical 
elements in the bones can also results from a variation 
of levels in soils leading to secondary migration to the 
bones. Soil contamination  results from the emission 
of chemical elements to the environment by industrial 
activity [5]. It is important for bone tissue to maintain 
mineral homeostasis. The disruption of mineral homeo-
stasis can lead to bone metabolic diseases, especially 
osteoporosis. Therefore, it is important to determine the 
level of these elements in bones [6, 11]. Wiśniewska 
[33] analyzed the concentration of Ca, Cd, Cu, Fe, K, 
Mg, Na, P, Pb, S, Sr, and Zn in the bone samples taken 
from patients after joint replacement. She investigated 
whether there was a positive correlation between the 
content of elements in the bones (especially Cd and 
Pb) and the condition of bone tissue. The data suggest 
that these relationships do exist. Other studies found 
relationships between the concentration of elements in 
the bones and external factors (diet, alcohol, physical 
activity). We report on the impact of environmental 
stressors on the level of chemical elements in the bones 
and the responses of bone to these elements [33].
Pro-antioxidant system of the body and 
the condition of bone tissue
It is estimated that up to 5% of oxygen absorbed 
by the body can be converted to reactive oxygen spe-
cies. ROS can be affected by exogenous and endoge-
nous factors. Exogenous factors which contribute to the 
formation of ROS include air pollution, tobacco smoke, 
ultraviolet light and ionizing radiation. However, the pri-
mary source is from the inner mitochondrial respiratory 
chain, carried out by the oxidoreductase reactions and 
the reactions of cytochrome P-450 [84–85]. High activity 
of ROS causes degenerative processes in cells , includ-
ing lipid peroxidation, protein oxidation, and nucleic 
acid structure disorders [86, 87]. Aerobic processes 
have evolved protective mechanisms  to maintain the 
physiological level of ROS. Specialized oxidative en-
zymes control on the level of antioxidants. They reduce 
the production of reactive oxygen species [19, 88–89]. 
Superoxide dismutase catalyzes the reactions in which 
the basic anions produce hydrogen peroxides and su-
peroxide. Catalase is responsible for the neutralization 
of hydrogen peroxide by conversion to water and oxy-
gen [19, 90]. A positive effect of supplementation with 
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copper antioxidant enzymes (CAT, GPx) in patients with 
osteoarthritis is known. This may reflect an antioxidant 
capacity of copper [20]. The body’s antioxidant barrier is 
reinforced by the presence of acute phase proteins: e.g. 
ceruloplasmin, ferritin, and haptoglobin, occurring main-
ly in the plasma. Their protective action is due to the 
chelation of metal ions, responsible for the production 
of free radicals [21]. Oxidative stress occurs when the 
activity of antioxidant control mechanisms is reduced 
causing increased ROS generation. Altindag et al. [29] 
suggest a negative correlation between OSI (oxidative 
stress index) and BMD in the patients with osteoporo-
sis after menopause. This means that BMD decreases 
with increasing oxidative stress. The increased activity 
of osteoclasts and the inhibition of osteoblast activity, 
in patients with postmenopausal osteoporosis, may 
be the result of an imbalance in oxidation-antioxidant 
mechanisms [29]. 
The relationships between the level of activity of 
antioxidant enzymes and physical activity have been 
analyzed. These studies involved patients with short-
term and long-term hypokinesia resulting in impaired 
physiological and biochemical reactions, leading to 
degenerative arthritis and bone metabolism distur-
bances. The data show that limited physical activity can 
disrupt the balance of oxidation-reduction and stimulate 
ROS formation. This suggests that increased activity of 
superoxide dismutase occurs in patients with reduced 
mobility [22–25]. However, in other studies, hypokinesis 
was found at low levels of antioxidant enzymes, which 
influenced pro-antioxidant processes [27–28, 91]. 
SOD activity can be further enhanced by melatonin 
supplementation and the activity of catalase-chromium 
compounds [25, 90]. Reactive oxygen species begin the 
process of lipid peroxidation, which results in increased 
levels of MDA in bones, that is cytotoxic and mutagenic 
and may contribute to carcinogenesis [26]. The level 
of MDA is significantly reduced in the patients after hip 
replacement and forced reduction of physical activity. 
This demonstrates the functionality of the antioxidant 
system in inhibiting lipid peroxidation [22–24].
The results reported by various authors [22–25, 
27–28, 91–92] are ambiguous. This justifies a  recon-
sideration of the role of antioxidant enzymes in the 
patients with cardiovascular diseases on bones and 
joints. This will contribute to a more complete picture of 
the response of bone tissue to different external stress-
ors. Analyses of the activity of antioxidant enzymes 
in patients will provide information on the defensive 
reaction mechanisms during environmental stressors 
[33]. The pathogenesis of diseases of bones and joints 
indicates the participation of ROS in the formation and 
development of osteoporosis, rheumatoid arthritis, 
and osteoarthritis [22–24, 86–87, 93–94]. Increasing 
oxidative stress may contribute to the development of 
diabetic bone disorders [79]. However, the role of the 
ROS in the pathogenesis of diseases of bones and joints 
is still unclear. Examination of the activity of antioxidant 
enzymes in patients will lead to better diagnosis of these 
diseases and more appropriate pharmacological inter-
ventions that can significantly reduce oxidative stress.
In summary, we analyzed specific relationships 
between the degrees of accumulation of physiologically 
different chemical elements in human bone in industrial-
ized areas. This review shows the association between 
exposure arising from smoking, the effect of amalgam 
dental fillings, as well as diet and food preferences, 
and the level of chemical elements, lipoperoxidation 
and reactions of pro-antioxidative systems in hu-
mans. They are important for the patient survey, taking 
into account possible stress factors (tobacco, alcohol, 
dental amalgams, diet, disease, hereditary conditions, 
and occupational and environmental exposure to toxic 
agents). They show direct relationships between the 
level of chemical elements in the body and degree of 
response to external stressors. These analyses make 
relevant comparisons within groups of external sub-
jects. They indicate the importance of external factors 
in the development of defense capabilities of the human 
skeleton. They also play a decisive role in the diagnosis 
of bone diseases.
conclusions
Specific relationships between the degrees of 
accumulation of physiologically different chemical 
elements in human bone and the scale of the problem 
in industrialized areas allows accurate identification 
of responses from parallel physiological systems. We 
presented to what extent humans are the link between 
exposure arising from smoking, the effect of amalgam 
dental fillings, as well as diet, food preferences, and 
the level of chemical elements, lipoperoxidation and 
pro-antioxidative reactions. They are important for the 
patient, taking into account stress factors. They have 
direct relationships with the level of chemical elements 
in the body and affect the degree of response to exter-
nal factors. These indicate the importance of external 
factors in the development of defense capabilities of 
the human skeletal system. They also play a decisive 
role in the diagnosis of bone diseases. 
1. An important factor determining the condition of 
the human skeletal system in anthropogenic areas 
is environmental destabilization. The physiology 
of the osteoarticular system results in undesirable 
accumulation of toxic elements (Pb, Cd, Hg, Ni, Cr, 
Al) in bones, which may potentially be involved in 
the pathogenesis of bone diseases.
2. Multiple exposures to harmful external factors may 
lead to pathological changes in the osteoarticular 
system. Diseases including osteoporosis, osteo-
Piotr Kamiński et al., The condition of human skeletal system
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arthritis, rheumatoid arthritis, systemic lupus ery-
thematosus, systemic sclerosis, osteomalacia and 
gout are influenced by surrounding environment 
factors such as diet, drugs, low physical activity and 
occupational exposure to chemicals.
3. Relationships between the antioxidant system and 
bone condition predict the potential risks in certain 
diseases of the osteoarticular system and systemic 
connective tissue diseases and suggest action to re-
duce oxidative stress. They develop the response of 
disturbed skeletal system to environmental stressors 
associated with the impact of toxic ions.
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